A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)
Clinical trial NCT01447420 · COMPLETED
Trial details
- NCT number
- NCT01447420
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-11-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.